The Prevalence of Lower Urinary Tract Symptoms in Individuals With Chronic Obstructive Pulmonary Disease
Investigation of the Prevalence of Lower Urinary Tract Symptoms and the Level of Knowledge About Pelvic Floor Health in Individuals With Chronic Obstructive Pulmonary Disease
1 other identifier
observational
30
1 country
1
Brief Summary
Chronic Obstructive Pulmonary Disease (COPD) is a chronic lung disease characterized by airflow limitations and respiratory symptoms due to structural changes in the airways. Common symptoms include dyspnea, chronic cough, and increased sputum production. Respiratory diseases are a risk factor for lower urinary tract symptoms, which can lead to leakage if pelvic floor muscles are weak. Lower urinary tract symptoms are classified into storage, emptying, and post-emptying groups. Current literature on urinary incontinence in COPD patients is limited, and there is a need for further research on the presence and effects of lower urinary system symptoms in individuals with COPD and the level of pelvic floor health knowledge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2025
CompletedFirst Submitted
Initial submission to the registry
April 27, 2025
CompletedFirst Posted
Study publicly available on registry
May 6, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 6, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2026
CompletedSeptember 11, 2025
September 1, 2025
1 year
April 27, 2025
September 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Incontinence Quality of Life Scale (IQOL)
The Turkish validity and reliability studies of the scale developed by Patrick et al. (1999) to determine the quality of life of patients with urinary incontinence were conducted by Özerdoğan et al. There are 22 questions in the scale and each question is evaluated with a Likert-type scale divided into five categories (1: very much, 2: quite, 3: moderately, 4: a little, 5: not at all). IQOL has three sub-dimensions: limiting behaviour, psychological impact and limiting social life. The total score of the scale ranges from 0-100 and it is concluded that the higher the score, the better the quality of life level.
Enrolllment
St George Respiratory Questionnaire (SGRQ)
Quality of life will be evaluated using the SGRQ, which includes symptoms, activity, and impact domains. Scores range from 0 to 100, with higher scores indicating poorer quality of life.
Enrollment
Secondary Outcomes (3)
International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF)
Enrollment
International Consultation on Incontinence Questionnaire-Male Lower Urinary System Symptoms (ICIQ-MLUTS)
Enrollment
International Consultation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms (ICIQ-FLUTS)
Enrollment
Other Outcomes (2)
Pelvic Floor Health Knowledge Test
Enrollment
Prolapse and Incontinence Knowledge Questionnaire
Enrollment
Interventions
\- St George Respiratory Questionnaire (SGRQ): The SGRQ developed by Jones (2000), which is used specifically for respiratory diseases, consists of 50 questions. In the questionnaire, there are three categories in which symptom, activity and the effect of the disease on quality of life are questioned and each category is evaluated within itself and there is an evaluation scale between 0-100 points. In the evaluation, high scores indicate an inadequate and low quality of life.
Eligibility Criteria
COPD patients who agreed to participate in the study
You may qualify if:
- Being diagnosed with COPD (according to GOLD criteria)
- Being clinically stable
- Volunteering to participate in the study
You may not qualify if:
- Having perception and cognitive problems
- Having a diagnosis of unstable COPD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kutahya Helath Sciences University- Health Sciences Faculty
Kütahya, Center, 43020, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assos. Prof.
Study Record Dates
First Submitted
April 27, 2025
First Posted
May 6, 2025
Study Start
January 6, 2025
Primary Completion
January 6, 2026
Study Completion
January 6, 2026
Last Updated
September 11, 2025
Record last verified: 2025-09